Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
Stay updated with breaking news from Barbaraj Mann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
The antibodies generated by Pfizer's COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.
A new study from UVA Health finds that the antibodies generated by Pfizer’s COVID-19 vaccine rise more slowly and decline more quickly.
Business Scoop provides news and views on Business and Markets from New Zealand
/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...